King's College London
- Address
- Strand
Sponsor Overview
Specializations
Retinal Disease and Macular Disorders
King's College London is involved in clinical research focused on exudative age-related macular degeneration, with particular attention to complications affecting the central retina and visual function.
- Wet age-related macular degeneration
- Submacular haemorrhage
- Macular pathology
The sponsor's activity in this area reflects interest in conditions that threaten central vision and require specialised ophthalmic care.
Vitreoretinal Surgery
Its clinical portfolio includes research in vitrectomy and other vitreoretinal interventions used in the management of haemorrhagic complications associated with retinal disease.
- Vitrectomy
- Subretinal intervention
- Ophthalmic surgical treatment
This area highlights involvement in procedural approaches for complex posterior segment eye disease.
Anti-VEGF and Retinal Pharmacotherapy
Research activity also extends to anti-VEGF therapy, a key treatment domain in retinal vascular disease and neovascular complications of macular degeneration.
- Intravitreal anti-VEGF treatment
- Neovascular retinal disease
- Intravitreal therapy
The sponsor is engaged in clinical questions surrounding pharmacologic control of abnormal retinal blood vessel growth and related visual loss.
Posterior Segment Eye Care
King's College London supports research addressing disorders of the posterior segment of the eye, where retinal damage and blood accumulation can lead to severe impairment.
- Subretinal TPA
- Intravitreal gas
- Vision-threatening retinal complications
These interests place emphasis on specialised treatment strategies for advanced ophthalmic disease.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Phase 3 Randomized Controlled Trial of Vitrectomy, Subretinal Alteplase, and Intravitreal Aflibercept for Submacular Hemorrhage in Exudative Age-Related Macular Degeneration |  Germany Ireland Poland Spain The Netherlands | Recruiting |
Data & Insights
This sponsor works with 2 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 19 sites across their trial portfolio.
Therapeutic Focus
- 1.Eye Diseases1 trial138 other sponsors
Partnered Research Centres
19 centres- Address
- Hindenburgdamm 30, Lichterfelde, 12203 Berlin
- Address
- Passeig De La Vall D'Hebron 119-129, 08035 Barcelona
- Address
- Unit 24-26, IDA Industrial Park Cork Road, X91 DC96 Waterford
- Address
- Ul. Rojna 90, 91-134 Lodz
- Address
- Kriegsbergstrasse 60, Mitte, 70174 Stuttgart
- Address
- Bremserstrasse 79, Friesenheim, 67063 Ludwigshafen am Rhein
Want to get in touch with this sponsor?
Send a question and we'll pass it on to King's College London.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.